{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:58:58Z","timestamp":1773914338303,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","award":["56867737"],"award-info":[{"award-number":["56867737"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016018","name":"Universidad El Bosque","doi-asserted-by":"publisher","award":["UEB 2021-655"],"award-info":[{"award-number":["UEB 2021-655"]}],"id":[{"id":"10.13039\/100016018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vhri.2025.101550","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T23:40:09Z","timestamp":1765582809000},"page":"101550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cost-Analysis of Adherence to Antimicrobial Guidelines as Part of Antimicrobial Stewardship Strategies in 6 Latin American Countries: A Pilot Experience Focusing on Economic Impact"],"prefix":"10.1016","volume":"51","author":[{"given":"Natalia","family":"Restrepo-Arbel\u00e1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elkin V.","family":"Lemos-Luengas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Garc\u00eda-Betancur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Cornistein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo","family":"Boldim-Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Ahumada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Chaverri-Murillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Casta\u00f1eda-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Hercilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Virginia","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Santonato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Valdebenito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaivet","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa Yasm\u00edn","family":"Vente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2025.101550_bib2","series-title":"Fiscal Sustainability of Health Systems: Bridging Health and Finance Perspectives","first-page":"23","article-title":"Fiscal sustainability of health systems\u2014why is it an issue, what can be done?","year":"2015"},{"key":"10.1016\/j.vhri.2025.101550_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106103","article-title":"Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome","volume":"170","author":"Pulingam","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.vhri.2025.101550_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.722927","article-title":"An introduction to the main types of economic evaluations used for informing priority setting and resource allocation in healthcare: key features, uses, and limitations","volume":"9","author":"Turner","year":"2021","journal-title":"Front Public Health"},{"issue":"11","key":"10.1016\/j.vhri.2025.101550_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmi.2017.08.026","article-title":"ESGAP (ESCMID Study Group for Antimicrobial stewardshiP). What is antimicrobial stewardship?","volume":"23","author":"Dyar","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.vhri.2025.101550_bib7","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1017\/ash.2021.210","article-title":"Interventions to optimize antimicrobial stewardship","volume":"1","author":"Tinker","year":"2021","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"6435","key":"10.1016\/j.vhri.2025.101550_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau4679","article-title":"The challenge of antimicrobial resistance: what economics can contribute","volume":"364","author":"Roope","year":"2019","journal-title":"Science"},{"issue":"10325","key":"10.1016\/j.vhri.2025.101550_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vhri.2025.101550_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijantimicag.2015.04.007","article-title":"The need for cost-effectiveness analyses of antimicrobial stewardship programmes: a structured review","volume":"46","author":"Coulter","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.vhri.2025.101550_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jhin.2019.03.002","article-title":"The economic impact of antimicrobial stewardship programmes in hospitals: a systematic literature review","volume":"102","author":"Huebner","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.vhri.2025.101550_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12913-016-1565-5","article-title":"A cost analysis of introducing an infectious disease specialist-guided antimicrobial stewardship in an area with relatively low prevalence of antimicrobial resistance","volume":"16","author":"Lanbeck","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.vhri.2025.101550_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s12879-023-08398-3","article-title":"Antimicrobial stewardship programs in seven Latin American countries: facing the challenges","volume":"23","author":"Pallares","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vhri.2025.101550_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14787210.2020.1813023","article-title":"Update on the epidemiology of carbapenemases in Latin America and the Caribbean","volume":"19","author":"Garc\u00eda-Betancur","year":"2021","journal-title":"Expert Rev Anti-infect Ther"},{"key":"10.1016\/j.vhri.2025.101550_bib15","article-title":"The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis","volume":"25","year":"2023","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"10.1016\/j.vhri.2025.101550_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12939-021-01426-1","article-title":"Understanding inequities in health and health systems in Latin America and the Caribbean: a thematic series","volume":"20","author":"Ruano","year":"2021","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.vhri.2025.101550_bib17","series-title":"Health policy and finance challenges in Latin America and the Caribbean: an economic perspective. Oxford Research Encyclopedia of Economics and Finance","author":"Medici","year":"2019"},{"issue":"1","key":"10.1016\/j.vhri.2025.101550_bib18","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2022.47","article-title":"Antimicrobial stewardship in Latin America: past, present, and future","volume":"2","author":"Fabre","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"6","key":"10.1016\/j.vhri.2025.101550_bib19","first-page":"387","article-title":"Addressing challenges in antibiotic access: barriers, implications and strategies for solution","volume":"38","author":"Bhandari","year":"2024","journal-title":"Pharmaceut Med"},{"key":"10.1016\/j.vhri.2025.101550_bib20","series-title":"Stemming the Superbug Tide: Just A Few Dollars More","year":"2018"},{"issue":"11","key":"10.1016\/j.vhri.2025.101550_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/11313670-000000000-00000","article-title":"Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region","volume":"27","author":"Augustovski","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.vhri.2025.101550_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13561-020-00298-5","article-title":"Micro-costing in health and medicine: a critical appraisal","volume":"11","author":"Xu","year":"2021","journal-title":"Health Econ Rev"},{"key":"10.1016\/j.vhri.2025.101550_bib23","series-title":"Cost-Effectiveness in Health and Medicine","year":"2016"},{"issue":"11","key":"10.1016\/j.vhri.2025.101550_bib24","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41433-022-02108-0","article-title":"Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis","volume":"36","author":"Parpia","year":"2022","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.vhri.2025.101550_bib25","first-page":"742","article-title":"Costs of appropriate and inappropriate use of antibiotics in the emergency department","volume":"12","author":"Ojeniran","year":"2010","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"10.1016\/j.vhri.2025.101550_bib26","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"2","author":"Davey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.vhri.2025.101550_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13756-020-00751-4","article-title":"The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre\u2014post analysis","volume":"9","author":"Al-Omari","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"10.1016\/j.vhri.2025.101550_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bjid.2016.02.005","article-title":"A cost-effectiveness analysis of two different antimicrobial stewardship programs","volume":"20","author":"Okumura","year":"2016","journal-title":"Braz J Infect Dis"},{"issue":"12","key":"10.1016\/j.vhri.2025.101550_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079747","article-title":"Antibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission rates","volume":"8","author":"Boyles","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vhri.2025.101550_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11096-010-9475-9","article-title":"Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study","volume":"33","author":"Dunn","year":"2011","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"10.1016\/j.vhri.2025.101550_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajic.2012.02.021","article-title":"Clinical and economic outcomes from a community hospital\u2019s antimicrobial stewardship program","volume":"41","author":"Malani","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vhri.2025.101550_bib32","series-title":"Applied Methods of Cost-Benefit Analysis in Health Care","first-page":"55","article-title":"Costing methodology for applied cost-benefit analysis in healthcare","author":"McIntosh","year":"2010"},{"issue":"1","key":"10.1016\/j.vhri.2025.101550_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13561-020-0260-8","article-title":"The use of micro-costing in economic analyses of surgical interventions: a systematic review","volume":"10","author":"Potter","year":"2020","journal-title":"Health Econ Rev"},{"issue":"9","key":"10.1016\/j.vhri.2025.101550_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4067\/s0034-98872018000900968","article-title":"Long-term impact of competitive biddings and an antimicrobial stewardship program in a general hospital in Chile","volume":"146","author":"Fica","year":"2018","journal-title":"Rev Med Chil"},{"issue":"4","key":"10.1016\/j.vhri.2025.101550_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0123-9392(12)70013-9","article-title":"Implementaci\u00f3n de un programa de uso regulado de antibi\u00f3ticos en 2 unidades de cuidado intensivo medico-quir\u00fargico en un hospital universitario de tercer nivel en Colombia","volume":"16","author":"Pallares","year":"2012","journal-title":"Infectio"},{"issue":"1","key":"10.1016\/j.vhri.2025.101550_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4067\/S0716-10182020000100009","article-title":"Impacto de un programa de optimizaci\u00f3n de uso de antimicrobianos en un hospital pedi\u00e1trico de tercer nivel en Panam\u00e1 [Impact of an antimicrobial stewardship program in a pediatric third level hospital in Panama]","volume":"37","author":"Rojas-Bonilla","year":"2020","journal-title":"Rev Chil Infectol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925004765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925004765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:03:33Z","timestamp":1773896613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925004765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"alternative-id":["S2212109925004765"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101550","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Analysis of Adherence to Antimicrobial Guidelines as Part of Antimicrobial Stewardship Strategies in 6 Latin American Countries: A Pilot Experience Focusing on Economic Impact","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101550"}}